new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2150 hits with Last Name = 'shen' and Initial = 'y'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144761
PNG
(US8952128, 20)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCCS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O12S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-107(105,106)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0200 -61.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144762
PNG
(US8952128, 21)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C86H110N18O13S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-118(116,117)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0200 -61.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144757
PNG
(US8952128, 15)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C86H110N18O12S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-117(116)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+,117?/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0200 -61.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
HIV-1 protease


(Human immunodeficiency virus)
BDBM104102
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-3-[(6-benzothia...)
Show SMILES CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(NC(C)=O)[C@@H](C)CC)S(=O)(=O)c1ccc2ncsc2c1 |r|
Show InChI InChI=1S/C30H42N4O5S2/c1-6-20(3)17-34(41(38,39)24-13-14-25-28(16-24)40-19-31-25)18-27(36)26(15-23-11-9-8-10-12-23)33-30(37)29(21(4)7-2)32-22(5)35/h8-14,16,19-21,26-27,29,36H,6-7,15,17-18H2,1-5H3,(H,32,35)(H,33,37)/t20-,21-,26-,27+,29?/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.0210n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
HIV-1 protease M2


(Human immunodeficiency virus)
BDBM104102
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-3-[(6-benzothia...)
Show SMILES CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(NC(C)=O)[C@@H](C)CC)S(=O)(=O)c1ccc2ncsc2c1 |r|
Show InChI InChI=1S/C30H42N4O5S2/c1-6-20(3)17-34(41(38,39)24-13-14-25-28(16-24)40-19-31-25)18-27(36)26(15-23-11-9-8-10-12-23)33-30(37)29(21(4)7-2)32-22(5)35/h8-14,16,19-21,26-27,29,36H,6-7,15,17-18H2,1-5H3,(H,32,35)(H,33,37)/t20-,21-,26-,27+,29?/m0/s1
PDB
MMDB

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.0280n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144737
PNG
(US8952128, 1)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C78H101FN16O9/c1-47(96)69-77(104)93-63(41-50-30-32-54(79)33-31-50)70(97)84-35-14-12-26-60(83-36-16-22-51-38-57-56-24-15-28-59-68(56)53(45-87-59)43-67(57)95(2)46-51)71(98)88-62(29-17-37-85-78(81)82)72(99)90-64(39-48-18-5-3-6-19-48)74(101)91-65(40-49-20-7-4-8-21-49)75(102)92-66(42-52-44-86-58-25-10-9-23-55(52)58)76(103)89-61(73(100)94-69)27-11-13-34-80/h3-10,15,18-21,23-25,28,30-33,44-45,47,51,57,60-67,69,83,86-87,96H,11-14,16-17,22,26-27,29,34-43,46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0400 -59.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144758
PNG
(US8952128, 16)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](CCCCNC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C101H133N21O14S2/c1-60(123)92-100(134)119-82(45-62-30-32-70(124)33-31-62)93(127)107-38-14-11-25-79(112-53-69(113-89(126)59-138(136)57-65-43-75-73-23-16-28-78-91(73)68(52-111-78)49-87(75)122(3)55-65)20-10-13-37-106-88(125)58-137(135)56-64-42-74-72-22-15-27-77-90(72)67(51-110-77)48-86(74)121(2)54-64)94(128)114-81(29-17-39-108-101(103)104)95(129)116-83(44-61-18-5-4-6-19-61)97(131)117-84(46-63-34-40-105-41-35-63)98(132)118-85(47-66-50-109-76-24-8-7-21-71(66)76)99(133)115-80(96(130)120-92)26-9-12-36-102/h4-8,15-16,18-19,21-24,27-28,30-35,40-41,50-52,60,64-65,69,74-75,79-87,92,109-112,123-124H,9-14,17,20,25-26,29,36-39,42-49,53-59,102H2,1-3H3,(H,106,125)(H,107,127)(H,113,126)(H,114,128)(H,115,133)(H,116,129)(H,117,131)(H,118,132)(H,119,134)(H,120,130)(H4,103,104,108)/t60-,64-,65-,69+,74-,75-,79-,80+,81+,82+,83+,84+,85-,86-,87-,92+,137?,138?/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0400 -59.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144755
PNG
(US8952128, 13)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C87H110FN17O12S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-118(117)50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+,118?/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0400 -59.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144770
PNG
(US8952128, 28A)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@@H](Cc1ccc(O)cc1)NCCCN(C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)C(C)=O |r|
Show InChI InChI=1/C90H117FN18O11/c1-55(110)81-89(120)106-75(47-60-30-34-64(91)35-31-60)82(113)96-39-15-13-26-72(100-52-65(43-59-32-36-66(112)37-33-59)95-41-18-42-109(56(2)111)54-61-44-69-68-24-16-28-71-80(68)63(51-99-71)49-79(69)108(3)53-61)83(114)101-74(29-17-40-97-90(93)94)84(115)103-76(45-57-19-6-4-7-20-57)86(117)104-77(46-58-21-8-5-9-22-58)87(118)105-78(48-62-50-98-70-25-11-10-23-67(62)70)88(119)102-73(85(116)107-81)27-12-14-38-92/h4-11,16,19-25,28,30-37,50-51,55,61,65,69,72-79,81,95,98-100,110,112H,12-15,17-18,26-27,29,38-49,52-54,92H2,1-3H3,(H,96,113)(H,101,114)(H,102,119)(H,103,115)(H,104,117)(H,105,118)(H,106,120)(H,107,116)(H4,93,94,97)/t55-,61-,65-,69-,72-,73+,74+,75+,76+,77+,78-,79-,81+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0400 -59.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
HIV-1 protease


(Human immunodeficiency virus)
BDBM104101
PNG
(MIT-2-AD-93 (AD-93))
Show SMILES CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1)S(=O)(=O)c1ccc2ncsc2c1 |r|
Show InChI InChI=1S/C29H33N3O5S2/c1-3-20(2)17-32(39(36,37)24-12-13-25-28(16-24)38-19-30-25)18-27(34)26(14-21-8-5-4-6-9-21)31-29(35)22-10-7-11-23(33)15-22/h4-13,15-16,19-20,26-27,33-34H,3,14,17-18H2,1-2H3,(H,31,35)/t20-,26-,27+/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
0.0460n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
HIV-1 protease M3


(Human immunodeficiency virus)
BDBM104102
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-3-[(6-benzothia...)
Show SMILES CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(NC(C)=O)[C@@H](C)CC)S(=O)(=O)c1ccc2ncsc2c1 |r|
Show InChI InChI=1S/C30H42N4O5S2/c1-6-20(3)17-34(41(38,39)24-13-14-25-28(16-24)40-19-31-25)18-27(36)26(15-23-11-9-8-10-12-23)33-30(37)29(21(4)7-2)32-22(5)35/h8-14,16,19-21,26-27,29,36H,6-7,15,17-18H2,1-5H3,(H,32,35)(H,33,37)/t20-,21-,26-,27+,29?/m0/s1
PDB
MMDB

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.0480n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
HIV-1 protease M2


(Human immunodeficiency virus)
BDBM104107
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-2-hydroxy-3-[[(...)
Show SMILES CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)C)S(=O)(=O)c1ccc(OC)cc1 |r|
Show InChI InChI=1S/C29H43N3O6S/c1-7-21(4)28(30-22(5)33)29(35)31-26(17-23-11-9-8-10-12-23)27(34)19-32(18-20(2)3)39(36,37)25-15-13-24(38-6)14-16-25/h8-16,20-21,26-28,34H,7,17-19H2,1-6H3,(H,30,33)(H,31,35)/t21-,26-,27+,28-/m0/s1
PDB
MMDB

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
Article
PubMed
0.0490n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144766
PNG
(US8952128, 25)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H99N17O11S/c1-45(95)68-76(105)92-61(36-47-23-25-52(96)26-24-47)69(98)82-30-11-9-20-58(86-66(97)44-106-43-49-34-55-54-17-12-21-57-67(54)51(41-85-57)39-65(55)94(2)42-49)70(99)87-60(22-13-31-83-77(79)80)71(100)89-62(35-46-14-4-3-5-15-46)73(102)90-63(37-48-27-32-81-33-28-48)74(103)91-64(38-50-40-84-56-18-7-6-16-53(50)56)75(104)88-59(72(101)93-68)19-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,40-41,45,49,55,58-65,68,84-85,95-96H,8-11,13,19-20,22,29-31,34-39,42-44,78H2,1-2H3,(H,82,98)(H,86,97)(H,87,99)(H,88,104)(H,89,100)(H,90,102)(H,91,103)(H,92,105)(H,93,101)(H4,79,80,83)/t45-,49-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0500 -58.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144752
PNG
(US8952128, 11)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0500 -58.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144756
PNG
(US8952128, 14)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C78H101FN16O10S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-106(105)46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+,106?/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0500 -58.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor


(Rattus norvegicus (rat))
BDBM21397
PNG
(8-[4-(4-fluorophenyl)-4-keto-butyl]-1-phenyl-1,3,8...)
Show SMILES Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1
Show InChI InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)
Reactome pathway
KEGG

GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents

PubMed
0.0600n/an/an/an/an/an/an/an/a



Case Western Reserve University

Curated by PDSP Ki Database




J Pharmacol Exp Ther 268: 1403-10 (1994)


BindingDB Entry DOI: 10.7270/Q2154FJQ
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144753
PNG
(US8952128, 12 | US8952128, 46)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106-/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0600 -58.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Serotonin (5-HT) receptor


(Rattus norvegicus (rat))
BDBM50007692
PNG
(8-[4-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-bu...)
Show SMILES O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1nsc2ccccc12
Show InChI InChI=1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents

PubMed
0.0600n/an/an/an/an/an/an/an/a



Case Western Reserve University

Curated by PDSP Ki Database




J Pharmacol Exp Ther 268: 1403-10 (1994)


BindingDB Entry DOI: 10.7270/Q2154FJQ
More data for this
Ligand-Target Pair
HIV-1 protease


(Human immunodeficiency virus)
BDBM104104
PNG
(N-[(1S,2R)-3-[(6-Benzothiazolylsulfonyl)(3-phenylp...)
Show SMILES O[C@H](CN(CCCc1ccccc1)S(=O)(=O)c1ccc2ncsc2c1)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1 |r|
Show InChI InChI=1S/C33H33N3O5S2/c37-27-15-7-14-26(20-27)33(39)35-30(19-25-11-5-2-6-12-25)31(38)22-36(18-8-13-24-9-3-1-4-10-24)43(40,41)28-16-17-29-32(21-28)42-23-34-29/h1-7,9-12,14-17,20-21,23,30-31,37-38H,8,13,18-19,22H2,(H,35,39)/t30-,31+/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
0.0700n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144759
PNG
(US8952128, 17)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](CCCCNC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C101H133N21O13S2/c1-61(123)92-100(133)119-82(45-62-21-6-4-7-22-62)93(126)107-39-17-14-30-79(112-54-70(113-89(125)60-137(135)58-66-44-75-73-28-19-33-78-91(73)69(53-111-78)50-87(75)122(3)56-66)25-13-16-38-106-88(124)59-136(134)57-65-43-74-72-27-18-32-77-90(72)68(52-110-77)49-86(74)121(2)55-65)94(127)114-81(34-20-40-108-101(103)104)95(128)116-83(46-63-23-8-5-9-24-63)97(130)117-84(47-64-35-41-105-42-36-64)98(131)118-85(48-67-51-109-76-29-11-10-26-71(67)76)99(132)115-80(96(129)120-92)31-12-15-37-102/h4-11,18-19,21-24,26-29,32-33,35-36,41-42,51-53,61,65-66,70,74-75,79-87,92,109-112,123H,12-17,20,25,30-31,34,37-40,43-50,54-60,102H2,1-3H3,(H,106,124)(H,107,126)(H,113,125)(H,114,127)(H,115,132)(H,116,128)(H,117,130)(H,118,131)(H,119,133)(H,120,129)(H4,103,104,108)/t61-,65-,66-,70+,74-,75-,79-,80+,81+,82+,83+,84+,85-,86-,87-,92+,136?,137?/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0800 -57.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144757
PNG
(US8952128, 15)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C86H110N18O12S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-117(116)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+,117?/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0800 -57.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144748
PNG
(US8952128, 7)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O10S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-105-45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0800 -57.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144765
PNG
(US8952128, 24)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H99N17O10S/c1-46(95)68-76(104)92-61(36-47-17-5-3-6-18-47)69(97)82-31-14-12-25-58(86-66(96)45-105-44-50-35-55-54-22-15-26-57-67(54)52(42-85-57)40-65(55)94(2)43-50)70(98)87-60(27-16-32-83-77(79)80)71(99)89-62(37-48-19-7-4-8-20-48)73(101)90-63(38-49-28-33-81-34-29-49)74(102)91-64(39-51-41-84-56-23-10-9-21-53(51)56)75(103)88-59(72(100)93-68)24-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,41-42,46,50,55,58-65,68,84-85,95H,11-14,16,24-25,27,30-32,35-40,43-45,78H2,1-2H3,(H,82,97)(H,86,96)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,83)/t46-,50-,55-,58-,59+,60+,61+,62+,63+,64-,65-,68+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0800 -57.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144752
PNG
(US8952128, 11)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NCC[S@](=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O11S/c1-46(95)68-76(104)92-62(38-48-23-25-53(96)26-24-48)69(97)83-30-11-9-19-59(82-34-35-106(105)45-50-36-56-55-17-12-21-58-67(55)52(43-86-58)41-66(56)94(2)44-50)70(98)87-61(22-13-31-84-77(79)80)71(99)89-63(37-47-14-4-3-5-15-47)73(101)90-64(39-49-27-32-81-33-28-49)74(102)91-65(40-51-42-85-57-18-7-6-16-54(51)57)75(103)88-60(72(100)93-68)20-8-10-29-78/h3-7,12,14-18,21,23-28,32-33,42-43,46,50,56,59-66,68,82,85-86,95-96H,8-11,13,19-20,22,29-31,34-41,44-45,78H2,1-2H3,(H,83,97)(H,87,98)(H,88,103)(H,89,99)(H,90,101)(H,91,102)(H,92,104)(H,93,100)(H4,79,80,84)/t46-,50-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+,106+/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0900 -57.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144764
PNG
(US8952128, 23)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C77H101N17O9S/c1-47(95)68-76(103)92-62(38-48-17-5-3-6-18-48)69(96)83-31-14-12-24-59(82-35-36-104-46-51-37-56-55-22-15-26-58-67(55)53(44-86-58)42-66(56)94(2)45-51)70(97)87-61(27-16-32-84-77(79)80)71(98)89-63(39-49-19-7-4-8-20-49)73(100)90-64(40-50-28-33-81-34-29-50)74(101)91-65(41-52-43-85-57-23-10-9-21-54(52)57)75(102)88-60(72(99)93-68)25-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,43-44,47,51,56,59-66,68,82,85-86,95H,11-14,16,24-25,27,30-32,35-42,45-46,78H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,79,80,84)/t47-,51-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.0900 -57.3n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
HIV-1 protease M4


(Human immunodeficiency virus)
BDBM104102
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-3-[(6-benzothia...)
Show SMILES CC[C@H](C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)C(NC(C)=O)[C@@H](C)CC)S(=O)(=O)c1ccc2ncsc2c1 |r|
Show InChI InChI=1S/C30H42N4O5S2/c1-6-20(3)17-34(41(38,39)24-13-14-25-28(16-24)40-19-31-25)18-27(36)26(15-23-11-9-8-10-12-23)33-30(37)29(21(4)7-2)32-22(5)35/h8-14,16,19-21,26-27,29,36H,6-7,15,17-18H2,1-5H3,(H,32,35)(H,33,37)/t20-,21-,26-,27+,29?/m0/s1
PDB
MMDB

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
0.0920n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144740
PNG
(US8952128, 4)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C86H110N18O11S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-116-50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.120 -56.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
HIV-1 protease


(Human immunodeficiency virus)
BDBM104103
PNG
(N-[(1S,2R)-3-[(6-Benzothiazolylsulfonyl)(cyclohexy...)
Show SMILES O[C@H](CN(CC1CCCCC1)S(=O)(=O)c1ccc2ncsc2c1)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1 |r|
Show InChI InChI=1S/C31H35N3O5S2/c35-25-13-7-12-24(17-25)31(37)33-28(16-22-8-3-1-4-9-22)29(36)20-34(19-23-10-5-2-6-11-23)41(38,39)26-14-15-27-30(18-26)40-21-32-27/h1,3-4,7-9,12-15,17-18,21,23,28-29,35-36H,2,5-6,10-11,16,19-20H2,(H,33,37)/t28-,29+/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
0.129n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144750
PNG
(US8952128, 9)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](CCCCNC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C101H133N21O11S2/c1-61(123)92-100(133)119-82(45-62-21-6-4-7-22-62)93(126)107-39-17-14-30-79(112-54-70(113-89(125)60-135-58-66-44-75-73-28-19-33-78-91(73)69(53-111-78)50-87(75)122(3)56-66)25-13-16-38-106-88(124)59-134-57-65-43-74-72-27-18-32-77-90(72)68(52-110-77)49-86(74)121(2)55-65)94(127)114-81(34-20-40-108-101(103)104)95(128)116-83(46-63-23-8-5-9-24-63)97(130)117-84(47-64-35-41-105-42-36-64)98(131)118-85(48-67-51-109-76-29-11-10-26-71(67)76)99(132)115-80(96(129)120-92)31-12-15-37-102/h4-11,18-19,21-24,26-29,32-33,35-36,41-42,51-53,61,65-66,70,74-75,79-87,92,109-112,123H,12-17,20,25,30-31,34,37-40,43-50,54-60,102H2,1-3H3,(H,106,124)(H,107,126)(H,113,125)(H,114,127)(H,115,132)(H,116,128)(H,117,130)(H,118,131)(H,119,133)(H,120,129)(H4,103,104,108)/t61-,65-,66-,70+,74-,75-,79-,80+,81+,82+,83+,84+,85-,86-,87-,92+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.130 -56.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144772
PNG
(US8952128, 29A)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCCN(C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)C(C)=O |r|
Show InChI InChI=1/C81H106FN17O10/c1-49(100)72-80(109)96-66(42-53-30-32-57(82)33-31-53)73(102)87-35-15-13-26-63(86-37-18-38-99(50(2)101)48-54-39-60-59-24-16-28-62-71(59)56(46-90-62)44-70(60)98(3)47-54)74(103)91-65(29-17-36-88-81(84)85)75(104)93-67(40-51-19-6-4-7-20-51)77(106)94-68(41-52-21-8-5-9-22-52)78(107)95-69(43-55-45-89-61-25-11-10-23-58(55)61)79(108)92-64(76(105)97-72)27-12-14-34-83/h4-11,16,19-25,28,30-33,45-46,49,54,60,63-70,72,86,89-90,100H,12-15,17-18,26-27,29,34-44,47-48,83H2,1-3H3,(H,87,102)(H,91,103)(H,92,108)(H,93,104)(H,94,106)(H,95,107)(H,96,109)(H,97,105)(H4,84,85,88)/t49-,54-,60-,63-,64+,65+,66+,67+,68+,69-,70-,72+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.130 -56.4n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144771
PNG
(US8952128, 29)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)N(CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C95H123N19O9S2/c1-58(115)86-94(123)110-77(45-59-19-6-4-7-20-59)87(116)100-35-15-13-31-81(114(39-41-124-56-62-43-70-68-24-16-28-73-84(68)65(52-103-73)49-82(70)112(2)54-62)40-42-125-57-63-44-71-69-25-17-29-74-85(69)66(53-104-74)50-83(71)113(3)55-63)93(122)106-76(30-18-36-101-95(97)98)88(117)107-78(46-60-21-8-5-9-22-60)90(119)108-79(47-61-32-37-99-38-33-61)91(120)109-80(48-64-51-102-72-26-11-10-23-67(64)72)92(121)105-75(89(118)111-86)27-12-14-34-96/h4-11,16-17,19-26,28-29,32-33,37-38,51-53,58,62-63,70-71,75-83,86,102-104,115H,12-15,18,27,30-31,34-36,39-50,54-57,96H2,1-3H3,(H,100,116)(H,105,121)(H,106,122)(H,107,117)(H,108,119)(H,109,120)(H,110,123)(H,111,118)(H4,97,98,101)/t58-,62-,63-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.140 -56.2n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
HIV-1 protease M4


(Human immunodeficiency virus)
BDBM104107
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-2-hydroxy-3-[[(...)
Show SMILES CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)C)S(=O)(=O)c1ccc(OC)cc1 |r|
Show InChI InChI=1S/C29H43N3O6S/c1-7-21(4)28(30-22(5)33)29(35)31-26(17-23-11-9-8-10-12-23)27(34)19-32(18-20(2)3)39(36,37)25-15-13-24(38-6)14-16-25/h8-16,20-21,26-28,34H,7,17-19H2,1-6H3,(H,30,33)(H,31,35)/t21-,26-,27+,28-/m0/s1
PDB
MMDB

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
Article
PubMed
0.144n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
HIV-1 protease


(Human immunodeficiency virus)
BDBM104107
PNG
((2S,3S)-2-(Acetylamino)-N-[(1S,2R)-2-hydroxy-3-[[(...)
Show SMILES CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)C)S(=O)(=O)c1ccc(OC)cc1 |r|
Show InChI InChI=1S/C29H43N3O6S/c1-7-21(4)28(30-22(5)33)29(35)31-26(17-23-11-9-8-10-12-23)27(34)19-32(18-20(2)3)39(36,37)25-15-13-24(38-6)14-16-25/h8-16,20-21,26-28,34H,7,17-19H2,1-6H3,(H,30,33)(H,31,35)/t21-,26-,27+,28-/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
0.146n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144745
PNG
(US8952128, 6C)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2cccc(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C78H101FN16O9S/c1-47(96)69-77(104)93-63(40-50-22-15-23-54(79)36-50)70(97)84-32-14-12-27-60(83-34-35-105-46-51-37-57-56-25-16-29-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(30-17-33-85-78(81)82)72(99)90-64(38-48-18-5-3-6-19-48)74(101)91-65(39-49-20-7-4-8-21-49)75(102)92-66(41-52-43-86-58-26-10-9-24-55(52)58)76(103)89-61(73(100)94-69)28-11-13-31-80/h3-10,15-16,18-26,29,36,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,17,27-28,30-35,37-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.150 -56.1n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144760
PNG
(US8952128, 19)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C87H110FN17O13S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-119(117,118)50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.160 -55.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144751
PNG
(US8952128, 10)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C78H101FN16O11S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-107(105,106)46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.160 -55.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Serotonin (5-HT) receptor


(Rattus norvegicus (rat))
BDBM21392
PNG
(3-(2-aminoethyl)-1H-indole-5-carboxamide | 5-CT | ...)
Show SMILES NCCc1c[nH]c2ccc(cc12)C(N)=O
Show InChI InChI=1S/C11H13N3O/c12-4-3-8-6-14-10-2-1-7(11(13)15)5-9(8)10/h1-2,5-6,14H,3-4,12H2,(H2,13,15)
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents

Article
PubMed
0.160n/an/an/an/an/an/an/an/a



National Institute of Neurological Disorders and Stroke

Curated by PDSP Ki Database




J Biol Chem 268: 18200-4 (1993)


Article DOI: 10.1021/cb500917m
BindingDB Entry DOI: 10.7270/Q2V1239R
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144751
PNG
(US8952128, 10)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C78H101FN16O11S/c1-47(96)69-77(104)93-63(40-50-28-30-54(79)31-29-50)70(97)84-33-14-12-24-60(83-35-36-107(105,106)46-51-37-57-56-22-15-26-59-68(56)53(44-87-59)42-67(57)95(2)45-51)71(98)88-62(27-16-34-85-78(81)82)72(99)90-64(38-48-17-5-3-6-18-48)74(101)91-65(39-49-19-7-4-8-20-49)75(102)92-66(41-52-43-86-58-23-10-9-21-55(52)58)76(103)89-61(73(100)94-69)25-11-13-32-80/h3-10,15,17-23,26,28-31,43-44,47,51,57,60-67,69,83,86-87,96H,11-14,16,24-25,27,32-42,45-46,80H2,1-2H3,(H,84,97)(H,88,98)(H,89,103)(H,90,99)(H,91,101)(H,92,102)(H,93,104)(H,94,100)(H4,81,82,85)/t47-,51-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.170 -55.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144778
PNG
(US8952128, 35)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)N(CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)CCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C95H123N19O10S2/c1-57(115)86-94(124)110-77(45-59-27-29-66(116)30-28-59)87(117)100-34-12-10-26-81(114(38-40-125-55-61-42-70-68-19-13-23-73-84(68)64(51-103-73)48-82(70)112(2)53-61)39-41-126-56-62-43-71-69-20-14-24-74-85(69)65(52-104-74)49-83(71)113(3)54-62)93(123)106-76(25-15-35-101-95(97)98)88(118)107-78(44-58-16-5-4-6-17-58)90(120)108-79(46-60-31-36-99-37-32-60)91(121)109-80(47-63-50-102-72-21-8-7-18-67(63)72)92(122)105-75(89(119)111-86)22-9-11-33-96/h4-8,13-14,16-21,23-24,27-32,36-37,50-52,57,61-62,70-71,75-83,86,102-104,115-116H,9-12,15,22,25-26,33-35,38-49,53-56,96H2,1-3H3,(H,100,117)(H,105,122)(H,106,123)(H,107,118)(H,108,120)(H,109,121)(H,110,124)(H,111,119)(H4,97,98,101)/t57-,61-,62-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.170 -55.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor


(Rattus norvegicus (rat))
BDBM79181
PNG
(10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoro...)
Show SMILES CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1
Show InChI InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3
Reactome pathway
KEGG

GoogleScholar
AffyNet 
Purchase

DrugBank
KEGG
PC cid
PC sid
PDB
UniChem
PubMed
0.190n/an/an/an/an/an/an/an/a



Case Western Reserve University

Curated by PDSP Ki Database




J Pharmacol Exp Ther 268: 1403-10 (1994)


BindingDB Entry DOI: 10.7270/Q2154FJQ
More data for this
Ligand-Target Pair
HIV-1 protease


(Human immunodeficiency virus)
BDBM104106
PNG
(MIT-2-KB-83 (KB-83))
Show SMILES COc1ccc(cc1)S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)c1cccc(O)c1 |r|
Show InChI InChI=1S/C28H34N2O6S/c1-20(2)18-30(37(34,35)25-14-12-24(36-3)13-15-25)19-27(32)26(16-21-8-5-4-6-9-21)29-28(33)22-10-7-11-23(31)17-22/h4-15,17,20,26-27,31-32H,16,18-19H2,1-3H3,(H,29,33)/t26-,27+/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
MMDB
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
0.194n/an/an/an/an/an/an/an/a



Massachusetts Institute of Technology



Assay Description
HIV protease inhibitor activities were determined by fluorescence resonance energy transfer (FRET) method. Protease substrate, Arg-Glu-(EDANS)-Ser-G...


ACS Chem Biol 8: 2433-41 (2013)


Article DOI: 10.1021/cb400468c
BindingDB Entry DOI: 10.7270/Q2R2101Z
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Androgen Receptor


(Homo sapiens (Human))
BDBM18161
PNG
((1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethy...)
Show SMILES [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C |r|
Show InChI InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
KEGG
MMDB
PC cid
PC sid
PDB
UniChem

Patents

PDB
Article
PubMed
0.200 -57.6n/an/a 5.10n/an/a7.437



Ligand Pharmaceuticals Inc.



Assay Description
The compounds were evaluated in a transcriptional activation assay with hAR in a mammalian cell background (CV-1) as the primary in vitro assay. Rece...


J Med Chem 50: 5049-52 (2007)


Article DOI: 10.1021/jm070231h
BindingDB Entry DOI: 10.7270/Q29Z935Z
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Androgen Receptor


(Homo sapiens (Human))
BDBM18161
PNG
((1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethy...)
Show SMILES [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C |r|
Show InChI InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
KEGG
MMDB
PC cid
PC sid
PDB
UniChem

Patents

PDB
Article
PubMed
0.200n/an/an/an/an/an/an/an/a



Ligand Pharmaceuticals

Curated by ChEMBL


Assay Description
Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay


Bioorg Med Chem Lett 18: 3431-5 (2008)


Article DOI: 10.1016/j.bmcl.2008.03.085
BindingDB Entry DOI: 10.7270/Q25M66J9
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144749
PNG
(US8952128, 8)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](CCCCNC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C101H133N21O12S2/c1-60(123)92-100(134)119-82(45-62-30-32-70(124)33-31-62)93(127)107-38-14-11-25-79(112-53-69(113-89(126)59-136-57-65-43-75-73-23-16-28-78-91(73)68(52-111-78)49-87(75)122(3)55-65)20-10-13-37-106-88(125)58-135-56-64-42-74-72-22-15-27-77-90(72)67(51-110-77)48-86(74)121(2)54-64)94(128)114-81(29-17-39-108-101(103)104)95(129)116-83(44-61-18-5-4-6-19-61)97(131)117-84(46-63-34-40-105-41-35-63)98(132)118-85(47-66-50-109-76-24-8-7-21-71(66)76)99(133)115-80(96(130)120-92)26-9-12-36-102/h4-8,15-16,18-19,21-24,27-28,30-35,40-41,50-52,60,64-65,69,74-75,79-87,92,109-112,123-124H,9-14,17,20,25-26,29,36-39,42-49,53-59,102H2,1-3H3,(H,106,125)(H,107,127)(H,113,126)(H,114,128)(H,115,133)(H,116,129)(H,117,131)(H,118,132)(H,119,134)(H,120,130)(H4,103,104,108)/t60-,64-,65-,69+,74-,75-,79-,80+,81+,82+,83+,84+,85-,86-,87-,92+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.210 -55.2n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144755
PNG
(US8952128, 13)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C87H110FN17O12S/c1-52(106)78-86(116)103-71(43-56-28-32-60(88)33-29-56)79(109)92-37-14-12-24-68(96-48-61(39-55-30-34-62(107)35-31-55)97-76(108)51-118(117)50-57-40-65-64-22-15-26-67-77(64)59(47-95-67)45-75(65)105(2)49-57)80(110)98-70(27-16-38-93-87(90)91)81(111)100-72(41-53-17-5-3-6-18-53)83(113)101-73(42-54-19-7-4-8-20-54)84(114)102-74(44-58-46-94-66-23-10-9-21-63(58)66)85(115)99-69(82(112)104-78)25-11-13-36-89/h3-10,15,17-23,26,28-35,46-47,52,57,61,65,68-75,78,94-96,106-107H,11-14,16,24-25,27,36-45,48-51,89H2,1-2H3,(H,92,109)(H,97,108)(H,98,110)(H,99,115)(H,100,111)(H,101,113)(H,102,114)(H,103,116)(H,104,112)(H4,90,91,93)/t52-,57-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+,118?/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.230 -55.0n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144776
PNG
(US8952128, 33)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C87H111N17O12S/c1-52(105)78-86(116)102-71(43-56-30-34-62(107)35-31-56)79(109)91-37-14-12-24-68(95-48-60(39-55-28-32-61(106)33-29-55)96-76(108)51-117-50-57-40-65-64-22-15-26-67-77(64)59(47-94-67)45-75(65)104(2)49-57)80(110)97-70(27-16-38-92-87(89)90)81(111)99-72(41-53-17-5-3-6-18-53)83(113)100-73(42-54-19-7-4-8-20-54)84(114)101-74(44-58-46-93-66-23-10-9-21-63(58)66)85(115)98-69(82(112)103-78)25-11-13-36-88/h3-10,15,17-23,26,28-35,46-47,52,57,60,65,68-75,78,93-95,105-107H,11-14,16,24-25,27,36-45,48-51,88H2,1-2H3,(H,91,109)(H,96,108)(H,97,110)(H,98,115)(H,99,111)(H,100,113)(H,101,114)(H,102,116)(H,103,112)(H4,89,90,92)/t52-,57-,60+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.240 -54.9n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144744
PNG
(US8952128, 6B)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2cc(F)cc(F)c2)NC1=O)NCCSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C78H100F2N16O9S/c1-46(97)69-77(105)94-63(38-49-33-53(79)41-54(80)34-49)70(98)85-29-14-12-24-60(84-31-32-106-45-50-35-57-56-22-15-26-59-68(56)52(43-88-59)40-67(57)96(2)44-50)71(99)89-62(27-16-30-86-78(82)83)72(100)91-64(36-47-17-5-3-6-18-47)74(102)92-65(37-48-19-7-4-8-20-48)75(103)93-66(39-51-42-87-58-23-10-9-21-55(51)58)76(104)90-61(73(101)95-69)25-11-13-28-81/h3-10,15,17-23,26,33-34,41-43,46,50,57,60-67,69,84,87-88,97H,11-14,16,24-25,27-32,35-40,44-45,81H2,1-2H3,(H,85,98)(H,89,99)(H,90,104)(H,91,100)(H,92,102)(H,93,103)(H,94,105)(H,95,101)(H4,82,83,86)/t46-,50-,57-,60-,61+,62+,63+,64+,65+,66-,67-,69+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.25 -54.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144789
PNG
(US8952128, 48)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O)NCCCS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C79H103FN16O11S/c1-48(97)70-78(105)94-64(41-51-29-31-55(80)32-30-51)71(98)85-34-14-12-25-61(84-36-17-37-108(106,107)47-52-38-58-57-23-15-27-60-69(57)54(45-88-60)43-68(58)96(2)46-52)72(99)89-63(28-16-35-86-79(82)83)73(100)91-65(39-49-18-5-3-6-19-49)75(102)92-66(40-50-20-7-4-8-21-50)76(103)93-67(42-53-44-87-59-24-10-9-22-56(53)59)77(104)90-62(74(101)95-70)26-11-13-33-81/h3-10,15,18-24,27,29-32,44-45,48,52,58,61-68,70,84,87-88,97H,11-14,16-17,25-26,28,33-43,46-47,81H2,1-2H3,(H,85,98)(H,89,99)(H,90,104)(H,91,100)(H,92,102)(H,93,103)(H,94,105)(H,95,101)(H4,82,83,86)/t48-,52-,58-,61-,62+,63+,64+,65+,66+,67-,68-,70+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.25 -54.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Serotonin (5-HT) receptor


(Rattus norvegicus (rat))
BDBM50001885
PNG
((risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-...)
Show SMILES Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12
Show InChI InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
PC cid
PC sid
PDB
UniChem

Patents

PubMed
0.25n/an/an/an/an/an/an/an/a



Case Western Reserve University

Curated by PDSP Ki Database




J Pharmacol Exp Ther 268: 1403-10 (1994)


BindingDB Entry DOI: 10.7270/Q2154FJQ
More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144773
PNG
(US8952128, 30 | US8952128, 32)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CSC[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |r|
Show InChI InChI=1/C87H111N17O11S/c1-53(105)78-86(115)102-71(42-54-20-6-3-7-21-54)79(108)91-38-17-15-29-68(95-49-61(40-57-33-35-62(106)36-34-57)96-76(107)52-116-51-58-41-65-64-27-18-31-67-77(64)60(48-94-67)46-75(65)104(2)50-58)80(109)97-70(32-19-39-92-87(89)90)81(110)99-72(43-55-22-8-4-9-23-55)83(112)100-73(44-56-24-10-5-11-25-56)84(113)101-74(45-59-47-93-66-28-13-12-26-63(59)66)85(114)98-69(82(111)103-78)30-14-16-37-88/h3-13,18,20-28,31,33-36,47-48,53,58,61,65,68-75,78,93-95,105-106H,14-17,19,29-30,32,37-46,49-52,88H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,89,90,92)/t53-,58-,61+,65-,68-,69+,70+,71+,72+,73+,74-,75-,78+/s2
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.280 -54.5n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 2150 total )  |  Next  |  Last  >>
Jump to: